This NKX2-5/CHD4-binding site-containing 488 bp cis-regulatory element (CRE) in the Acta1 3' UTR, suppressing Acta1 expression, was targeted with sgRNAs using CRISPR/Cas9 technology, resulting in the deletion of the CRE. (J:324708)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count